FDA
-
-
-
-
-
-
-
Real-World Evidence and Industry Momentum Builds for iMDx’s Flagship GraftAssure Assay
-
-
-
-
-
-
-
Insight Molecular Diagnostics Completes Key Milestones Advancing GraftAssureDx Toward FDA Submission
-
-
-
-
-
-
-
iMDx reports kidney transplant patient maintained graft without immunosuppression
-
-
-
-
-
-
-
Needham Reiterates Buy Rating on Insight Molecular Diagnostics Inc. (IMDX)
-
-
-
-
-
-
323,939 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

